Skip to content
Trial Eligibility
Menu

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT01034033

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer
  • Ovarian Cancer
  • Gynecologic Cancers
  • Ovarian/Peritoneal/Fallopian Cancer

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Stanford University
Last updated on ClinicalTrials.gov
May 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Stanford University School of Medicine · Stanford, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.